XPENG-MOTORS
Xpeng Motors, a leading electric vehicle and technology company, today reveals an exclusive inside view into its self-built wholly-owned factory in Zhaoqing, Guangdong Province.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200609005686/en/
The Zhaoqing Xpeng Motors Intelligent Industrial Park, birthplace of the super-long range sports sedan Xpeng P7, was built over a period of 15 months. On May 19, 2020 the factory received the official production license from China’s Ministry of Industry and Information Technology.
Find the pictures and videos revealing the interior of the factory here: https://drive.google.com/drive/folders/1RzxP_eVWDWwVdnfaYTt01G7hn3F-ZZeS?usp=sharing
“We are deeply proud of our achievement as a young company, in building our own wholly-owned smart manufacture base at Zhaoqing,” said He Xiaopeng, Chairman and CEO of Xpeng Motors.
“Xpeng is now the only new smart EV maker in China that has both self-owned and contracted plants. We are a firm believer that manufacturing is the foundation of smart cars. Only when you build solid powertrain and vehicle hardware, can you differentiate with data operation, autonomous driving and connectivity software,” He added.
“This not only gives us optimal insight into and control over our production process, it also demonstrates our capabilities in successfully managing our supply chain and executing major projects. This is a great base for future development in intelligent vehicle design and manufacture,” He concluded.
Spanning a planned area of 3,000 acres (2 million square metres), it has five cutting-edge workshops including stamping, welding, painting, final assembly, and battery pack production.
The factory is run by a 600-member professional team. 74% of the engineers are with 5+ year working experience with 78% joined from leading OEMs.
Stamping Workshop
The stamping workshop is 100% automated. Steel plates are stamped and formed on the 6,600-ton large CNC (computer numerical control) automatic stamping production line, delivering as many as 12 pieces per minute, higher than the 10% industry average, with a precision range as narrow as 0.1 millimeter.
Equipped with an industry-leading information system, the production process is highly open and transparent, with real-time monitoring of processing parameters to ensure high quality consistency.
Welding Workshop
The Zhaoqing welding workshop is equipped with 210 ABB industrial robots, meticulously performing multiple processes including gluing, welding and aluminum plate riveting. Tier-1 and Tier-2 final assemblies reach a 100% automation rate, with the capability to manufacture steel-aluminum hybrid vehicle bodies.
The factory’s self-adaptive medium frequency welding machine achieves 30% energy saving, while the advanced visual gluing system yields gluing accuracy as fine as 0.5 millimeter.
Painting Workshop
Sophisticated styling requires exceptional painting techniques. The Zhaoqing factory’s thin film pretreatment and cathode electrophoretic technology effectively reduces wastewater discharge, while slag yield is also cut down by 94%, reducing energy consumption by approximately 25%, and achieving zero emission of heavy metal pollutants.
The painting workshop adopts world-class BASF high-throwing-power coating material, with B1B2+2K water-based varnish double-layer painting technology, significantly improving paint quality while protecting the environment too.
Assembly Workshop
Thanks to an automatic material supply and distribution system, AGV technology, automatic gluing robots and assembly technology, all components are efficiently and meticulously assembled in the Zhaoqing factory.
All the key torque joints of CBUs (Complete Built Up) are tested online through a powerful digital production system, ensuring 100% quality control of all key torque joints of the build-up.
Battery Pack Workshop
The pack workshop utilizes an AGV flexible production line, combining high-precision visual systems and robots to execute intelligent operations. The intelligent end-of-line testing system conducts comprehensive testing – including 198 offline tests and 89 battery performance tests - for every battery pack, including insulation, SOC performance and BMS function to ensure that every battery pack meets the industry-leading IP68 sealing protection requirements.
The Xpeng P7 will go through 18 vigorous quality control procedures. Each vehicle will also go through over 1,700 dynamic and static tests, and 18 simulated road condition tests for control, braking, comfort, sealing, and abnormal sound to guarantee its quality.
Zhaoqing Xpeng Motors Intelligent Industrial Park – At a Glance
- Total planned area: 3,000 acres (2 million square metres)
- Vehicle production facilities area: 1,500 acres (1 million square metres).
- Phase 1 construction: 900 acres (600,000 square metres)
- Foundation-laying: December 2017
- Construction completion: September 2019
- MIIT production license: received on 19 May 2020
- Industry 4.0 standards
- Five workshops
- 264 intelligent industrial robots
For more P7 videos and images please visit: https://drive.google.com/open?id=1mjds6n51HszTF5YhDcbaViucSwLjeiio
About XPENG Motors
Xpeng Motors is a leading Chinese electric vehicle company that designs and manufactures automobiles that are seamlessly integrated with the Internet and utilize the latest advances in artificial intelligence. The company's initial backers include its Chairman & CEO, He Xiaopeng, who’s also the co-founder of UCWeb Inc. and a former Alibaba executive. Established in 2014, Xpeng Motors has a senior management team with diverse backgrounds, including Co-founders Henry Xia and He Tao, both former senior executives at Guangzhou Auto with expertise in innovative automotive technology and R&D, and Vice Chairman & President Brian Gu, former Chairman of Asia Pacific Investment Banking at J.P. Morgan. It has received funding from strategic investors Alibaba Group and Xiaomi Corporation, as well as other prominent Chinese and international investors including IDG Capital, Morningside Venture Capital, GGV Capital and Primavera Capital. The company launched its first production model, the G3 SUV, in Dec 2018, and will launch its second production model, the P7 electric sports sedan, in April 2020 with deliveries to Chinese customers in Q2 2020. Xpeng Motors is headquartered in Guangzhou, China with offices in Beijing, Shanghai, Silicon Valley and San Diego in the U.S. and manufacture centers in Zhengzhou and Zhaoqing. For more information, please visit the official website: https://en.xiaopeng.com/
Follow us on social media for latest Xpeng news:
Facebook Twitter LinkedIn YouTube Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20200609005686/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom